DNMT3A -448A>G polymorphism and cancer risk: a meta-analysis.

C H Liu,T Tao,L Jiang,B Xu,L Zhang,K Lu,X W Zhang,S Q Chen,D C Liu,M Chen

DOI: https://doi.org/10.4238/2015.April.17.14

2015-01-01

Genetics and Molecular Research

Abstract:Cancer is a major public health problem worldwide that involves complex processes and factors. For instance, methylation is important in tumorigenesis. DNA (cytosine-5)-methyltransferase 3A (DNMT3A) is the main de novo methyltransferase implicated in this process. In DNMT3A, the -448A>G polymorphism is associated with cancer; however, the results of various studies have been conflicting. To clarify the role of DNMT3A polymorphisms in cancer, we conducted a meta-analysis of 2014 cases and 3089 control subjects. Odds ratios with 95% confidence intervals were estimated to evaluate the association between the DNMT3A -448A>G polymorphism and cancer risk. The results showed that DNMT3A may be a protective factor against all cancer types and colorectal cancer groups. Further studies should be conducted including different ethnicities and large population sizes to generate a comprehensive conclusion.